Found 7 matching trials
Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines
PHASE3The purpose of this observer blind study is to assess the safety in terms o...
Location
GSK Investigational Site
Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants
PHASE2This study will assess the impact on nasopharyngeal carriage, safety and im...
Location
GSK Investigational Site
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine
PHASE3This study will evaluate safety, reactogenicity and immunogenicity of GSK B...
Location
GSK Investigational Site
Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix⢠Hib and Polio Sabinâ˘
PHASE3The purpose of this study is to assess the immunogenicity in terms of antib...
Location
GSK Investigational Site
Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants
PHASE2This purpose of the study is to assess the safety and immunogenicity of a G...
Location
GSK Investigational Site
Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI Regimen
PHASE2This study is being done to assess the possibility of the potential integra...
Location
GSK Investigational Site
Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)
PHASE3This study has been designed to support the indication of the candidate vac...
Location
GSK Investigational Site